Clinical Pharmacology and Drug Toxicity — MCQs
On this page
Pulmonary fibrosis is a known side effect of which of the following medications?
A 38-year-old woman being treated for hypertension and diabetes presents with the sudden onset of swelling and tenderness of the wrists and knees. On examination, she is febrile and flushed. A friction rub can be heard at the left lower sternal border. Which of the following drugs is most likely the cause of these findings?
In which phase of clinical trials is the efficacy of a new drug compared with an existing standard drug?
Which of the following drugs is contraindicated in liver dysfunction?
Disulfiram acts by blocking which enzyme?
Cholinesterase activators are useful for the treatment of which poisoning?
Which of the following adverse drug reactions (ADRs) is seen with withdrawal of the drug?
A 40-year-old man presents with altered mental status after ingesting an unknown medication in a suicide attempt. His vital signs include a temperature of 103°F, blood pressure of 120/85 mmHg, pulse of 100/min and irregular, and respiratory rate of 22/min. Physical examination reveals flushed and dry skin, dilated pupils, and muscle twitching. ECG shows prolonged QRS complexes, while hepatic transaminases are normal and arterial blood gas analysis shows a normal pH. These clinical findings are most consistent with intoxication by which of the following substances?
Sirolimus is prescribed to a post-renal transplantation client. The nurse expects which of the following laboratory results?
Which enzyme is inhibited by fomepizole?
Clinical Pharmacology and Drug Toxicity Indian Medical PG Practice Questions and MCQs
Question 11: Pulmonary fibrosis is a known side effect of which of the following medications?
- A. Bleomycin (Correct Answer)
- B. Cisplatin
- C. Methotrexate
- D. Actinomycin D
Explanation: **Explanation:** **Bleomycin** is a cytotoxic antibiotic used in cancer chemotherapy (e.g., Hodgkin’s lymphoma, testicular cancer). Its most significant and dose-limiting toxicity is **Pulmonary Fibrosis**. The underlying mechanism involves the drug’s inability to be inactivated in the lungs. While most tissues contain "Bleomycin hydrolase," the lungs and skin lack this enzyme. This leads to the accumulation of the drug, resulting in oxidative stress, DNA damage, and subsequent fibroblast proliferation, leading to "Bleomycin-induced lung injury." **Analysis of Incorrect Options:** * **B. Cisplatin:** Primarily known for its **Nephrotoxicity** (prevented by aggressive hydration and Amifostine) and Ototoxicity. It does not typically cause pulmonary fibrosis. * **C. Methotrexate:** While it can cause an acute hypersensitivity pneumonitis, its hallmark toxicities are **Myelosuppression** (rescued by Leucovorin), Mucositis, and Hepatotoxicity. * **D. Actinomycin D:** Mainly associated with myelosuppression and "radiation recall" phenomenon; it is not a classic cause of pulmonary fibrosis. **High-Yield Clinical Pearls for NEET-PG:** * **Monitoring:** Patients on Bleomycin must be monitored with **Pulmonary Function Tests (PFTs)**, specifically looking for a decrease in **DLCO** (Diffusion Capacity of Carbon Monoxide). * **Risk Factor:** The risk of fibrosis increases significantly when the cumulative dose exceeds **400 units**. * **Other Drugs causing Pulmonary Fibrosis:** Remember the mnemonic **"B-A-M"**: **B**leomycin, **A**miodarone, **M**usulfan (Busulfan), and **M**ethotrexate (rarely). * **Skin Toxicity:** Bleomycin also causes **Flagellate hyperpigmentation** of the skin.
Question 12: A 38-year-old woman being treated for hypertension and diabetes presents with the sudden onset of swelling and tenderness of the wrists and knees. On examination, she is febrile and flushed. A friction rub can be heard at the left lower sternal border. Which of the following drugs is most likely the cause of these findings?
- A. Metformin
- B. Hydralazine (Correct Answer)
- C. Minoxidil
- D. Nitroprusside
Explanation: **Explanation:** The clinical presentation of fever, joint pain (polyarthritis), and a pericardial friction rub (indicating pericarditis) in a patient on antihypertensive therapy is classic for **Drug-Induced Lupus Erythematosus (DILE)**. **1. Why Hydralazine is correct:** Hydralazine is a potent vasodilator used in resistant hypertension. It is one of the most common causes of DILE. The mechanism involves the accumulation of reactive metabolites that trigger an autoimmune response. A key high-yield feature of Hydralazine-induced lupus is its association with **"Slow Acetylators"** (individuals with a genetic deficiency in the N-acetyltransferase enzyme), who cannot metabolize the drug efficiently, leading to toxicity. **2. Why the other options are incorrect:** * **Metformin:** Primarily causes gastrointestinal upset or lactic acidosis; it does not cause lupus-like syndromes. * **Minoxidil:** While it can cause pericardial effusion, it typically presents with hypertrichosis (excessive hair growth) and fluid retention, not a systemic autoimmune/lupus-like picture. * **Nitroprusside:** Used for hypertensive emergencies; its main toxicity is cyanide or thiocyanate poisoning (presenting with altered mental status and metabolic acidosis). **3. NEET-PG High-Yield Pearls:** * **Hallmark Antibody:** Anti-histone antibodies are positive in >95% of DILE cases (Anti-dsDNA is usually negative, unlike systemic lupus). * **Common Culprits (SHIPP):** **S**ulfonamides, **H**ydralazine, **I**soniazid, **P**rocainamide, **P**henytoin. * **Clinical Distinction:** DILE rarely involves the CNS or Kidneys, which helps distinguish it from idiopathic SLE. * **Management:** Symptoms typically resolve upon discontinuation of the offending drug.
Question 13: In which phase of clinical trials is the efficacy of a new drug compared with an existing standard drug?
- A. Phase I
- B. Phase II
- C. Phase III (Correct Answer)
- D. Phase IV
Explanation: **Explanation:** The primary objective of **Phase III clinical trials** is to confirm the therapeutic benefit and safety of a new drug in a large patient population (usually 1,000–3,000 participants). This phase is characterized by **Comparative Studies**, where the new drug is compared against the current "Gold Standard" (existing treatment) or a placebo. This is essential to establish if the new drug offers any clinical advantage over existing therapies before it receives regulatory approval for marketing. **Analysis of Incorrect Options:** * **Phase I (Safety & Pharmacokinetics):** Conducted on a small group (20–80) of healthy volunteers. The goal is to determine the Maximum Tolerated Dose (MTD), safety profile, and pharmacokinetics, not efficacy. * **Phase II (Therapeutic Exploration):** Conducted on a small group (100–300) of actual patients. It aims to establish the "Proof of Concept," determine the dose-response relationship, and assess initial efficacy. It is usually not a comparative study against standard drugs. * **Phase IV (Post-Marketing Surveillance):** Occurs after the drug is launched in the market. It monitors long-term safety, rare side effects (e.g., Phocomelia with Thalidomide), and effects in special populations. **High-Yield Clinical Pearls for NEET-PG:** * **Phase 0:** Also known as **Microdosing** studies; used to determine human PK parameters using sub-therapeutic doses. * **Phase III:** Often referred to as the **"Pivotal Phase"** because its results determine the New Drug Application (NDA) submission. * **Phase II:** Has the highest failure rate in the drug development process. * **Phase IV:** Important for detecting **Idiosyncratic reactions** and rare adverse events not seen in controlled trials.
Question 14: Which of the following drugs is contraindicated in liver dysfunction?
- A. Pefloxacin (Correct Answer)
- B. Vancomycin
- C. Amikacin
- D. Hydralazine
Explanation: **Explanation:** The correct answer is **Pefloxacin**. **1. Why Pefloxacin is the correct answer:** Pefloxacin is a fluoroquinolone that is unique because it undergoes extensive **hepatic metabolism** (primarily via N-demethylation to norfloxacin). Unlike most other fluoroquinolones (like Ciprofloxacin or Levofloxacin) which are primarily excreted by the kidneys, Pefloxacin is eliminated mainly by the liver. In patients with liver dysfunction, its clearance is significantly reduced, leading to drug accumulation and increased risk of toxicity. Therefore, it is contraindicated or requires extreme caution in hepatic failure. **2. Why the other options are incorrect:** * **Vancomycin:** This glycopeptide is primarily excreted unchanged by the **kidneys**. It requires dose adjustment in renal failure, not liver failure. * **Amikacin:** As an aminoglycoside, it is highly polar and excreted entirely by **glomerular filtration**. It is nephrotoxic and ototoxic but does not depend on hepatic metabolism. * **Hydralazine:** While metabolized by the liver (acetylation), it is not contraindicated in liver dysfunction, though dose monitoring may be required. It is a classic cause of drug-induced Lupus. **3. NEET-PG High-Yield Pearls:** * **Fluoroquinolones & Excretion:** Most are renally excreted. **Pefloxacin and Moxifloxacin** are the notable exceptions that are primarily metabolized/excreted by the liver. * **Mnemonic for Liver-Excreted Drugs:** Remember "**D**on't **C**ause **M**ore **L**iver **P**roblems" — **D**oxycycline, **C**eftriaxone, **M**oxifloxacin/Macrolides, **L**incosamides (Clindamycin), **P**efloxacin. * **Safe in Renal Failure:** These drugs are often preferred in patients with kidney disease because they do not require renal dose adjustment.
Question 15: Disulfiram acts by blocking which enzyme?
- A. Alcohol dehydrogenase
- B. Acetaldehyde dehydrogenase (Correct Answer)
- C. Pyruvate dehydrogenase
- D. All of the above
Explanation: ### Explanation **Mechanism of Action** The correct answer is **Acetaldehyde dehydrogenase (ALDH)**. Alcohol metabolism primarily follows a two-step oxidative pathway: 1. **Alcohol → Acetaldehyde:** Catalyzed by Alcohol Dehydrogenase (ADH). 2. **Acetaldehyde → Acetic Acid:** Catalyzed by Acetaldehyde Dehydrogenase (ALDH). Disulfiram irreversibly inhibits **ALDH**. When a patient on Disulfiram consumes alcohol, acetaldehyde cannot be converted to acetic acid, leading to its accumulation in the blood. This results in the **Disulfiram-Ethanol Reaction (DER)**, characterized by flushing, tachycardia, nausea, vomiting, and hypotension, which serves as an aversion therapy for chronic alcoholism. **Analysis of Incorrect Options** * **A. Alcohol dehydrogenase:** This enzyme is inhibited by **Fomepizole**, which is used in the treatment of Methanol and Ethylene glycol poisoning to prevent the formation of toxic metabolites (formaldehyde and oxalic acid). * **C. Pyruvate dehydrogenase:** This is a mitochondrial enzyme complex that converts pyruvate to Acetyl-CoA. It is inhibited by Arsenic and is not involved in ethanol metabolism. **High-Yield Clinical Pearls for NEET-PG** * **Disulfiram-like reaction:** Several other drugs can cause a similar reaction when taken with alcohol. Mnemonic: **"PM Cans"** (**P**rocarbazine, **M**etronidazole, **C**efoperazone/Cefotetan, **A**ntazoline, **N**itrofurantoin, **S**ulfonylureas like Chlorpropamide). * **Duration of Action:** Because Disulfiram is an irreversible inhibitor, its effects can last for **7–14 days** even after stopping the drug, as the body must synthesize new ALDH enzymes. * **Contraindication:** It should never be administered if the patient has consumed alcohol within the last 12 hours.
Question 16: Cholinesterase activators are useful for the treatment of which poisoning?
- A. Paraquat
- B. Parathion (Correct Answer)
- C. Carbamates
- D. Organochlorocompounds
Explanation: **Explanation:** **1. Why Parathion is Correct:** Parathion is an **Organophosphate (OP)** compound. OPs act by irreversibly binding to the active site of the enzyme Acetylcholinesterase (AChE) via phosphorylation. This leads to an accumulation of acetylcholine and a "cholinergic crisis." **Cholinesterase activators (Oximes, e.g., Pralidoxime/PAM)** work by dephosphorylating the enzyme, thereby regenerating active AChE. However, they must be administered before "aging" (permanent covalent bonding) occurs. **2. Why Incorrect Options are Wrong:** * **Carbamates (Option C):** Unlike OPs, carbamates cause *reversible* carbamylation of AChE. The bond dissociates spontaneously within minutes to hours. Oximes are generally **not indicated** because they do not significantly speed up this recovery and may even inhibit the enzyme further (especially in Carbaryl poisoning). * **Paraquat (Option A):** This is a herbicide that causes severe pulmonary fibrosis through the generation of free radicals (oxidative stress). Treatment involves immunosuppression and antioxidants, not oximes. * **Organochlorocompounds (Option D):** These (e.g., DDT) are CNS stimulants that act on sodium channels. Treatment is symptomatic (e.g., benzodiazepines for seizures); they do not involve the cholinesterase enzyme. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Aging" Phenomenon:** Once the OP-enzyme complex "ages," oximes are no longer effective. * **Atropine vs. Oximes:** Atropine is the drug of choice for symptomatic relief (muscarinic effects) in both OP and Carbamate poisoning, but it does **not** reactivate the enzyme or treat muscle paralysis (nicotinic effects). * **Oxime Contraindication:** Pralidoxime is specifically contraindicated in **Carbaryl** (a carbamate) poisoning. * **Mnemonic:** "OPs need Oximes; Carbamates don't."
Question 17: Which of the following adverse drug reactions (ADRs) is seen with withdrawal of the drug?
- A. Strychnine
- B. Clonidine
- C. Morphine (Correct Answer)
- D. Baclofen
Explanation: ### Explanation **Correct Option: C. Morphine** The question asks for an adverse drug reaction (ADR) specifically associated with **drug withdrawal** (Type E reaction). Morphine, a potent opioid agonist, leads to significant physical dependence. Upon abrupt cessation, the body experiences a "rebound" effect because the compensatory mechanisms (like increased cAMP levels) are no longer suppressed. This results in a classic withdrawal syndrome characterized by lacrimation, rhinorrhea, yawning, sweating, and painful abdominal cramps. **Analysis of Incorrect Options:** * **A. Strychnine:** This is a potent neurotoxin that acts as a glycine antagonist. It causes severe **acute toxicity** (convulsions and opisthotonus) rather than a withdrawal syndrome. * **B. Clonidine:** While Clonidine is well-known for causing **rebound hypertension** upon sudden withdrawal, in the context of standard pharmacological classification and competitive exams, **Morphine** is the classic textbook prototype for physical dependence and withdrawal syndrome. (Note: If this were a "Multiple Select" style, Clonidine would also be correct, but Morphine is the primary answer in the context of addiction/dependence). * **D. Baclofen:** While abrupt withdrawal of Baclofen can cause seizures or hallucinations, it is primarily used for spasticity. Morphine remains the higher-yield answer for withdrawal-related ADRs in general pharmacology. **High-Yield Clinical Pearls for NEET-PG:** * **Type E ADRs (End-of-use):** These occur when a drug is stopped abruptly. Examples: Opioid withdrawal, Rebound hypertension (Clonidine, Beta-blockers), and Adrenal insufficiency (Steroids). * **Morphine Withdrawal Management:** The drug of choice for managing opioid withdrawal is **Methadone** (long-acting agonist) or **Buprenorphine** (partial agonist). **Clonidine** can be used to treat the autonomic symptoms of withdrawal. * **Naloxone vs. Naltrexone:** Naloxone is used for acute opioid overdose; Naltrexone is used for maintenance of opioid-free states.
Question 18: A 40-year-old man presents with altered mental status after ingesting an unknown medication in a suicide attempt. His vital signs include a temperature of 103°F, blood pressure of 120/85 mmHg, pulse of 100/min and irregular, and respiratory rate of 22/min. Physical examination reveals flushed and dry skin, dilated pupils, and muscle twitching. ECG shows prolonged QRS complexes, while hepatic transaminases are normal and arterial blood gas analysis shows a normal pH. These clinical findings are most consistent with intoxication by which of the following substances?
- A. Acetaminophen
- B. Alcohol
- C. Benzodiazepines
- D. Tricyclic antidepressants (Correct Answer)
Explanation: **Explanation:** The clinical presentation described is a classic case of **Tricyclic Antidepressant (TCA) overdose**. TCAs have a complex pharmacological profile that leads to a "toxidrome" characterized by three main features: **Anticholinergic effects, Cardiovascular toxicity, and CNS toxicity.** 1. **Anticholinergic effects:** Hyperthermia (103°F), flushed/dry skin ("Red as a beet, dry as a bone"), and dilated pupils (mydriasis). 2. **Cardiovascular toxicity:** TCAs inhibit fast sodium channels in the myocardium. This leads to **QRS prolongation** (the most reliable predictor of seizures and arrhythmias) and irregular pulse. 3. **CNS toxicity:** Altered mental status and muscle twitching/seizures. **Analysis of Incorrect Options:** * **A. Acetaminophen:** Toxicity primarily causes hepatic necrosis. Normal transaminases and the presence of anticholinergic signs rule this out. * **B. Alcohol:** Overdose typically presents with CNS depression, slurred speech, ataxia, and respiratory depression, not anticholinergic symptoms or QRS widening. * **C. Benzodiazepines:** These cause sedation and respiratory depression with normal pupils and stable vitals. They do not cause hyperthermia or ECG changes. **High-Yield NEET-PG Pearls:** * **ECG Marker:** A QRS duration **>100 ms** increases seizure risk; **>160 ms** increases the risk of ventricular arrhythmias. * **Management:** The specific antidote for TCA-induced cardiotoxicity is **Intravenous Sodium Bicarbonate**. It works by increasing extracellular sodium and alkalinizing the blood, which decreases the drug's affinity for sodium channels. * **Avoid:** Physostigmine is generally contraindicated in TCA overdose as it can worsen cardiac conduction delays.
Question 19: Sirolimus is prescribed to a post-renal transplantation client. The nurse expects which of the following laboratory results?
- A. Elevated serum potassium.
- B. Decreased cholesterol level.
- C. Elevated platelet count.
- D. Elevated triglyceride level. (Correct Answer)
Explanation: **Explanation:** **Sirolimus (Rapamycin)** is an immunosuppressant that inhibits the **mTOR (mammalian Target of Rapamycin)** pathway [1]. It is commonly used in renal transplantation to prevent graft rejection. **1. Why Option D is Correct:** The most characteristic metabolic side effect of Sirolimus is **hyperlipidemia**, specifically **elevated triglyceride levels** (hypertriglyceridemia) and hypercholesterolemia. This occurs because mTOR inhibition interferes with insulin signaling and lipid metabolism, leading to increased hepatic synthesis of VLDL and decreased activity of lipoprotein lipase (LPL). Monitoring the lipid profile is mandatory for patients on Sirolimus. **2. Why Other Options are Incorrect:** * **Option A (Elevated serum potassium):** Hyperkalemia is a classic side effect of **Calcineurin Inhibitors (CNIs)** like Cyclosporine and Tacrolimus, but it is not typically associated with Sirolimus. * **Option B (Decreased cholesterol level):** As mentioned, Sirolimus causes an *increase* in cholesterol levels, not a decrease. * **Option C (Elevated platelet count):** Sirolimus is known for causing **bone marrow suppression**, leading to anemia, leukopenia, and **thrombocytopenia** (decreased platelet count), rather than thrombocytosis. **Clinical Pearls for NEET-PG:** * **Mechanism:** Binds to **FKBP-12** to inhibit mTOR; it does *not* inhibit calcineurin (unlike Tacrolimus) [1]. * **Key Advantage:** Unlike Cyclosporine and Tacrolimus, Sirolimus is **not nephrotoxic**, making it ideal for renal transplant patients with impaired kidney function. * **Side Effects Profile:** Hyperlipidemia, thrombocytopenia, impaired wound healing, and interstitial pneumonitis. * **Drug-Eluting Stents:** Sirolimus is frequently used in coronary stents to prevent neointimal hyperplasia (restenosis).
Question 20: Which enzyme is inhibited by fomepizole?
- A. Alcohol dehydrogenase (Correct Answer)
- B. Acetaldehyde dehydrogenase
- C. Catalase
- D. Peroxidase
Explanation: **Explanation:** **Fomepizole** is a potent competitive inhibitor of the enzyme **Alcohol Dehydrogenase (ADH)**. This enzyme is the first and rate-limiting step in the metabolism of alcohols. By inhibiting ADH, fomepizole prevents the conversion of alcohols into their toxic metabolites. **Why Option A is Correct:** In cases of **Methanol** or **Ethylene Glycol** poisoning, the parent compounds are relatively non-toxic. However, ADH converts Methanol into **Formaldehyde** (and then Formic acid) and Ethylene Glycol into **Glycoaldehyde** (and then Oxalic acid). These metabolites cause metabolic acidosis, blindness, and renal failure. Fomepizole "shuts the gate" at the ADH level, allowing the parent alcohols to be excreted harmlessly by the kidneys. **Why Other Options are Incorrect:** * **B. Acetaldehyde Dehydrogenase (ALDH):** This enzyme is inhibited by **Disulfiram**. Inhibition leads to the accumulation of acetaldehyde, causing the "disulfiram-like reaction" (flushing, nausea, tachycardia). * **C & D. Catalase and Peroxidase:** While these enzymes play minor roles in alcohol oxidation in the liver and brain, they are not the primary targets for clinical intervention in toxicity cases. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice:** Fomepizole is the preferred antidote for Methanol and Ethylene Glycol poisoning over Ethanol because it does not cause CNS depression or hypoglycemia. * **Mnemonic:** **F**omepizole **F**orgets the **F**irst enzyme (ADH); **D**isulfiram inhibits the **D**one (second) enzyme (ALDH). * **Ethylene Glycol Toxicity:** Look for "Envelope-shaped" calcium oxalate crystals in urine. * **Methanol Toxicity:** Look for "Snowstorm vision" or optic disc hyperemia.
Practice by Chapter
Principles of Clinical Pharmacology
Practice Questions
Therapeutic Drug Monitoring
Practice Questions
Drug Toxicity and Overdose
Practice Questions
Antidotes and Their Applications
Practice Questions
Management of Drug Poisoning
Practice Questions
Drug-Induced Liver Injury
Practice Questions
Drug-Induced Kidney Injury
Practice Questions
Drug-Induced Blood Dyscrasias
Practice Questions
Drug-Induced QT Prolongation
Practice Questions
Pharmacovigilance
Practice Questions
Want unlimited practice?
Get full access to all questions, explanations, and performance tracking.
Start For Free